Community-acquired pneumonia: Clinical sciences

5,156views

Community-acquired pneumonia: Clinical sciences

Watch later

Watch later

Approach to hypertension: Clinical sciences
Chest X-ray interpretation: Clinical sciences
Acute mesenteric ischemia: Clinical sciences
Aortic dissection: Clinical sciences
Cardiac tamponade: Clinical sciences
Congestive heart failure: Clinical sciences
Hypovolemic shock: Clinical sciences
Infectious endocarditis: Clinical sciences
Mitral stenosis: Clinical sciences
Pericarditis: Clinical sciences
Peripheral arterial disease and ulcers: Clinical sciences
Right heart failure: Clinical sciences
Temporal arteritis: Clinical sciences
Valvular insufficiency (regurgitation): Clinical sciences
Approach to hyperthyroidism and thyrotoxicosis: Clinical sciences
Approach to hypothyroidism: Clinical sciences
Approach to hypoglycemia: Clinical sciences
Acute pancreatitis: Clinical sciences
Cushing syndrome and Cushing disease: Clinical sciences
Adrenal insufficiency: Clinical sciences
Diabetes mellitus (Type 1): Clinical sciences
Diabetes mellitus (Type 2): Clinical sciences
Hyperosmolar hyperglycemic state: Clinical sciences
Graves disease: Clinical Sciences
Diabetic ketoacidosis: Clinical sciences
Hashimoto thyroiditis: Clinical sciences
Hyperparathyroidism: Clinical sciences
Primary aldosteronism (hyperaldosteronism): Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Acetaminophen (Paracetamol) toxicity: Clinical sciences
Appendicitis: Clinical sciences
Cholecystitis: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Diverticulitis: Clinical sciences
Hepatic encephalopathy: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Ileus: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Large bowel obstruction: Clinical sciences
Peptic ulcer disease: Clinical sciences
Small bowel obstruction: Clinical sciences
Approach to bleeding disorders (coagulopathy): Clinical sciences
Approach to bleeding disorders (thrombocytopenia): Clinical sciences
Approach to bleeding disorders (platelet dysfunction): Clinical sciences
Approach to hypercoagulable disorders: Clinical sciences
Approach to leukemia: Clinical sciences
Iron deficiency anemia: Clinical sciences
Sickle cell disease: Clinical sciences
Vitamin B12 deficiency: Clinical sciences
Basal cell carcinoma: Clinical sciences
Burns: Clinical sciences
Lyme disease: Clinical sciences
Melanoma: Clinical sciences
Necrotizing soft tissue infections: Clinical sciences
Pressure-induced skin and soft tissue injury: Clinical sciences
Approach to lymphoma: Clinical sciences
Approach to hallucinogen, inhalant, and cannabis use, intoxication, and overdose: Clinical sciences
Approach to stimulant use, intoxication, and overdose: Clinical sciences
Approach to trauma and stressor-related disorders: Clinical sciences
Opioid intoxication and overdose: Clinical sciences
Bipolar I, bipolar II, and cyclothymic disorder: Clinical sciences
Opioid use disorder: Clinical sciences
Substance use disorder: Clinical sciences
Approach to a fever in the returned traveler: Clinical sciences
Approach to a postoperative fever: Clinical sciences
Approach to acid-base disorders: Clinical sciences
Approach to a fever: Clinical sciences
Approach to hypercalcemia: Clinical sciences
Approach to hyperkalemia: Clinical sciences
Approach to hyponatremia: Clinical sciences
Approach to metabolic alkalosis: Clinical sciences
Approach to nosocomial infections: Clinical sciences
Approach to metabolic acidosis: Clinical sciences
Approach to hypernatremia: Clinical sciences
Approach to respiratory acidosis: Clinical sciences
Approach to respiratory alkalosis: Clinical sciences
Infectious mononucleosis: Clinical sciences
Obesity and metabolic syndrome: Clinical sciences
Systemic lupus erythematosus: Clinical sciences
Tuberculosis (extrapulmonary and latent): Clinical sciences
Approach to unsteadiness, gait disturbance, or falls: Clinical sciences
Myasthenia gravis: Clinical sciences
Osteoarthritis: Clinical sciences
Septic arthritis: Clinical sciences
Spinal fractures: Clinical sciences
Rheumatoid arthritis: Clinical sciences
Spinal infection and abscess: Clinical sciences
Approach to aphasia: Clinical sciences
Approach to blunt traumatic cervical spine injuries: Clinical sciences
Approach to differentiating lesions (brainstem): Clinical sciences
Approach to differentiating lesions (cerebral cortical and subcortical structures): Clinical sciences
Approach to differentiating lesions (cerebellum): Clinical sciences
Approach to differentiating lesions (motor neuron): Clinical sciences
Approach to differentiating lesions (nerve root, plexus, and peripheral nerve): Clinical sciences
Approach to differentiating lesions (spinal cord): Clinical sciences
Approach to dysarthria or dysphagia: Clinical sciences
Approach to headache or facial pain: Clinical sciences
Approach to epilepsy: Clinical sciences
Approach to increased intracranial pressure: Clinical sciences
Approach to traumatic brain injury: Clinical sciences
Acute stroke (ischemic or hemorrhagic) or TIA: Clinical sciences
Delirium: Clinical sciences
Brain death: Clinical sciences
Diabetes insipidus: Clinical sciences
Guillain-Barré syndrome: Clinical sciences
Meningitis and brain abscess: Clinical sciences
Subarachnoid hemorrhage: Clinical sciences
Approach to lower limb edema: Clinical sciences
Approach to vasculitis: Clinical sciences
Deep vein thrombosis: Clinical sciences
Venous insufficiency and ulcers: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Approach to vaginal discharge: Clinical sciences
Chlamydia trachomatis infection: Clinical sciences
Neisseria gonorrhoeae infection: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Approach to dyspnea: Clinical sciences
Approach to pneumoperitoneum and peritonitis (perforated viscus): Clinical sciences
Acute respiratory distress syndrome: Clinical sciences
Asthma in pregnancy: Clinical sciences
Airway obstruction: Clinical sciences
Atelectasis: Clinical sciences
Asthma: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Empyema: Clinical sciences
Hospital-acquired and ventilator-associated pneumonia: Clinical sciences
Influenza: Clinical sciences
Pleural effusion: Clinical sciences
Pulmonary embolism: Clinical sciences
Pneumothorax: Clinical sciences
Upper respiratory tract infections: Clinical sciences
Tuberculosis (pulmonary): Clinical sciences
Approach to acute kidney injury: Clinical sciences
Catheter-associated urinary tract infection: Clinical sciences
Intrinsic acute kidney injury (glomerular causes): Clinical sciences
Chronic kidney disease: Clinical sciences
Intrinsic acute kidney injury (non-glomerular causes): Clinical sciences
Lower urinary tract infection: Clinical sciences
Postrenal acute kidney injury: Clinical sciences
Pyelonephritis: Clinical sciences
Prerenal acute kidney injury: Clinical sciences
Asthma: Information for patients and families (The Primary School)
Food allergies and EpiPens: Information for patients and families (The Primary School)
Empathetic listening for clinicians
Shared decision-making
Implicit bias
The do's and don'ts of patient care
Cardiovascular disease screening: Clinical sciences
Essential hypertension: Clinical sciences
Approach to a murmur (pediatrics): Clinical sciences
Carotid artery stenosis screening: Clinical sciences
Acute rheumatic fever and rheumatic heart disease: Clinical sciences
Randomized control trial
Clinical trials
Study designs
Bias in performing clinical studies
Problem-based learning
Sample size
Information bias
Selection bias
Case-control study
Cohort study
Hypothesis testing: One-tailed and two-tailed tests
Correlation
Paired t-test
Types of data
Bias in interpreting results of clinical studies
Two-sample t-test
The role of the kidney in acid-base balance
Anatomy of the glossopharyngeal nerve (CN IX)
Anticoagulants: Warfarin
Class I antiarrhythmics: Sodium channel blockers
Hepatitis A and Hepatitis E virus
Class IV antiarrhythmics: Calcium channel blockers and others
Anatomy clinical correlates: Oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy of the facial nerve (CN VII)
Anatomy of the vestibulocochlear nerve (CN VIII)
Anatomy clinical correlates: Glossopharyngeal (CN IX), vagus (X), spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy clinical correlates: Facial (CN VII) and vestibulocochlear (CN VIII) nerves
Anatomy of the trigeminal nerve (CN V)
Anatomy of the spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy of the vagus nerve (CN X)
Definitions of acids and bases
Anatomy clinical correlates: Trigeminal nerve (CN V)
Kidney stones: Pathology review
Meningitis
Cellulitis and erysipelas: Clinical sciences
Sepsis: Clinical sciences
Bacterial vaginosis: Clinical sciences
Aspiration pneumonia and pneumonitis: Clinical sciences
Clostridioides difficile infection: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Pneumonia is a lung infection that results in inflammation of one or both lungs. Usually, it is caused by bacteria, like Streptococcus pneumoniae; and viruses, such as influenza, but rarely, pneumonia can be caused by fungi as well.

Now, based on the setting in which pneumonia develops, we can subdivide it into two main types: community-acquired pneumonia, or CAP for short; and hospital-acquired pneumonia, or HAP. When a person develops pneumonia outside of a hospital or within 48 hours after the admission to hospital, it’s considered CAP.

On the other hand, HAP develops after 48 hours of the admission to hospital. Finally, there’s a special subtype of HAP called ventilator-acquired pneumonia, or VAP. VAP refers to pneumonia that occurs in individuals on mechanical ventilation, 48 hours after the endotracheal intubation.

The first thing to do when approaching a patient with suspected CAP is to obtain a focused history and physical examination; send labs, such as ABG, CBC and BMP; monitor pulse oximetry; and get a chest x-ray.

Let’s start with the history. Patients with CAP might report coughing, difficulty breathing, and chest pain during inspiration. Keep in mind that these symptoms develop either outside of the hospital or within 48 hours of admission. They may also have a history of risk factors like COPD, diabetes, smoking, or alcohol use.

Here are some high-yield facts to keep in mind! A productive cough can occur with bacterial infections. However, if the sputum is blood-tinged, consider specific organisms like Streptococcus pneumoniae, Klebsiella pneumoniae, or Legionella pneumophila.

Now, the physical examination often reveals an elevated temperature, tachypnea, and tachycardia. Pay close attention to lung auscultation, which might reveal rales over the affected area. Additionally, if there’s lobar consolidation, the physical exam might demonstrate bronchial breath sounds, egophony, and increased tactile fremitus in the affected lobe.

In contrast, patients with a pleural effusion might present with decreased breath sounds, decreased tactile fremitus, and dullness to chest percussion in the affected area.

Finally, pulse oximetry might reveal a drop in oxygen saturation, while chest X-ray can show new lung infiltrates.

Once you diagnosed CAP based on the history and physical, labs, and imaging studies, the next step is to determine its severity. This is where the pneumonia severity index, or PSI, comes in. PSI categorizes patients into 5 classes based on clinical elements like age and temperature; laboratory elements, such as BUN and glucose; and radiographic elements, like pleural effusion.

Now, let’s talk about low-risk CAP. Classes 1 to 3 are considered low-risk CAP and can be managed at home. The type of treatment is based on whether or not the person has any chronic medical conditions. So, if your patient has no chronic conditions, start them on oral amoxicillin or doxycycline for 5 days. However, if they do have a chronic condition, such as COPD or diabetes mellitus, then make sure to start them on an oral respiratory fluoroquinolone like levofloxacin or moxifloxacin, or a combination of an oral beta-lactam and a macrolide for 5 days.

Okay, let’s switch gears and talk about high-risk CAP. Classes 4 and 5 are considered high-risk CAP and require admission to the hospital. First, use the Infectious Diseases Society of America/ American Thoracic Society CAP criteria, better known as IDSA/ATS CAP criteria, to determine if they should be managed on the hospital floor, or in the ICU. IDSA/ATS CAP criteria include major criteria, such as septic shock or respiratory failure; and minor criteria, like elevated respiratory rate, confusion, uremia, high WBC count, low platelets, hypothermia, multilobar infiltrates, and hypotension.

Now, if your patient has no major or less than 3 minor criteria, admit them to the hospital floor and start them on supplemental oxygen to maintain oxygen saturation above 92%. Additionally, you should look for a causative pathogen, so don’t forget to obtain a blood culture, and a sputum sample for culture and gram stain. You can also test the urine and sputum for pneumococcal antigens. Finally, assess their symptoms daily to check how they are responding to treatment.

If your patient has 1 major or 3 or more minor criteria, admit them to the ICU and start the same treatment as you do for hospital floor patients. Additionally, if the patient presents with respiratory failure, put them on ventilatory support and periodically assess parameters to optimize oxygenation. However, if the patient presents with sepsis, you should also maintain their systolic blood pressure above 90 mmHg using IV fluids and vasopressors.

Sources

  1. "Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America" Am J Respir Crit Care Med (2019)
  2. "Comparing the pneumonia severity index with CURB-65 in patients admitted with community acquired pneumonia" Scand J Infect Dis (2008)
  3. "The pneumonia severity index: a decade after the initial derivation and validation" Clin Infect Dis (2008)
  4. "Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia" Chest (2022)
  5. "PES Pathogens in Severe Community-Acquired Pneumonia" Microorganisms (2019)
  6. "Management of pneumonia in critically ill patients" BMJ (2021)
  7. "Understanding the Host in the Management of Pneumonia. An Official American Thoracic Society Workshop Report" Ann Am Thorac Soc (2021)
  8. "Community-acquired pneumonia in the emergency department" Emerg Med Pract (2021)
  9. "Nucleic Acid-based Testing for Noninfluenza Viral Pathogens in Adults with Suspected Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline" Am J Respir Crit Care Med (2021)
  10. "The SIRS criteria have better performance for predicting infection than qSOFA scores in the emergency department" Sci Rep (2020)
  11. "A profile of delafloxacin in the treatment of adults with community-acquired bacterial pneumonia" Expert Rev Clin Pharmacol (2022)
  12. "A prediction model for hospital mortality in patients with severe community-acquired pneumonia and chronic obstructive pulmonary disease" Respir Res (2022)
  13. "Performance of the CURB-65 Score in Predicting Critical Care Interventions in Patients Admitted With Community-Acquired Pneumonia" Ann Emerg Med (2022)